Cardiovascular Clinical Trials Market Poised for Growth, Expected to Reach $7.03 Billion by 2028
Cardiovascular Clinical Trials Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's Cardiovascular Clinical Trials Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
LONDON, GREATER LONDON, UK, June 19, 2024 /EINPresswire.com/ -- The cardiovascular clinical trials market is projected to grow from $4.99 billion in 2023 to $5.34 billion in 2024, at a CAGR of 7.0%. This growth can be attributed to increased myocardial infarction, regulatory environment, increased disease burden, advancements in genomics, and increased demand for new drug development. The market is anticipated to reach $7.03 billion by 2028, at a CAGR of 7.1%.
Rising Incidence of Cardiovascular Diseases Fuels Growth of the Cardiovascular Clinical Trials Market
The growing incidence of cardiovascular diseases is expected to drive the growth of the cardiovascular clinical trials market going forward. Cardiovascular disease refers to a group of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, and stroke. There is an increased incidence of cardiovascular diseases due to various factors, such as sedentary lifestyles, unhealthy diets, smoking, obesity, high blood pressure, diabetes, and genetic predispositions. Cardiovascular clinical trials help in discovering and validating new drugs that can more effectively manage risk factors such as hypertension, high cholesterol, and diabetes, which are significant contributors to CVDs.
Explore comprehensive insights into the cardiovascular clinical trials market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=15532&type=smp
Major Players and Market Trends
Key players in the market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Baxter International Inc., IQVIA Holdings Inc., SGS S.A., PPD Inc., WuXi AppTec Co. Ltd., Caidya, Syneos Health Inc., Charles River Laboratories International Inc., Sanofi, ICON plc, Medpace Holdings Inc., Cardiovascular Clinical Sciences, ProRelix Services LLP, and Worldwide Clinical Trials.
Cereno Scientific Partners with CRO for Phase I Study
Major companies operating in the cardiovascular clinical trials market are focused on adopting strategic partnerships, such as contract research organization (CRO) partnerships, to expand their distribution networks and reach a wider customer base. A CRO partnership plays a crucial role in the clinical research industry and involves collaborations between different types of companies to provide specialized services and support for various aspects of clinical trials and research.
Segments:
•Phase: Phase I, Phase II, Phase III, Phase IV
•Study Design: Interventional, Observational, Expanded Access
•Indication: Acute Coronary Syndrome, Coronary Artery Disease, Ischemic Heart Disease, Pulmonary Arterial Hypertension, Stroke, Cardiac Arrhythmias, Heart Failure, Other Indications
Geographical Insights: North America Leading the Market
North America was the largest region in the cardiovascular clinical trials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Access the complete report for an in-depth analysis of the cardiovascular clinical trials market: https://www.thebusinessresearchcompany.com/report/cardiovascular-clinical-trials-global-market-report
Cardiovascular clinical trials refer to investigations that are aimed at new ways to prevent, diagnose, treat, and manage cardiovascular illnesses (CVDs), such as coronary artery disease, heart failure, arrhythmias, and hypertension. These studies are critical for expanding medical knowledge and improving patient care in the field of cardiology. The clinics focus on testing new medications, procedures, or devices related to heart health and stroke outcomes.
Cardiovascular Clinical Trials Global Market Report 2024 from TBRC covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Cardiovascular Clinical Trials Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on cardiovascular clinical trials market size, cardiovascular clinical trials market drivers and trends, cardiovascular clinical trials market major players, competitors' revenues, market positioning, and market growth across geographies. The cardiovascular clinical trials market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Cardiovascular Implants Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report
Cardiovascular Digital Solutions Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-digital-solutions-global-market-report
Cardiovascular Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
Curtains Up: Movie Theaters Market Insights, Growth Drivers, and Cinematic Innovations!
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
